Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Biostatisticians (US)(?)

Council Members in this Study Group: 270

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Jed Gorlin, MD
Transfusion Service Director
Hennepin County Medical Center

Jed Gorlin, MD, MBA, is the Medical Director of the Memorial Blood Center of Minnesota and an Associate Professor of Laboratory Medicine and Pediatrics at the University of Minnesota. Dr. Gorlin is also the Transfusion Services Director at Hennepin County Medical Center. His research includes the hematopoietic...

William Shannon, PhD
Founder and President
BioRankings, LLC

William Shannon, PhD, is a tenured Associate Professor of Biostatistics and the Director of Biostatistical Consulting Center in Department of Medicine at Washington University School of Medicine. He is responsible for research and development of new statistical methods for molecular data analysis, and...

Alfred Bartolucci, PhD
Professor
UNIVERSITY OF ALABAMA AT BIRMINGHAM

Alfred Bartolucci, PhD, is a Professor of Biostatistics at University of Alabama at Birmingham. Dr. Bartolucci’s areas of expertise in applied statistics are oncology , Alzheimer's disease, cardiovascular disease, statistical genetic association research, and Systemic Lupus Erythematosus. His areas...

Glenn Chertow, MD
Chief, Division of Nephrology
Stanford University School of Medicine

Glenn Chertow, MD, MPH, is Professor of Medicine and Chief, Division of Nephrology, at Stanford University School of Medicine and Director of Nephrology Services at Stanford Hospital and Clinics. His research interests are focused on epidemiology, health services research, and clinical trials in acute...

Charles Glueck, MD, Medical Research Director of Cholesterol Center, Jewish HospitalCharles Glueck, MD
Medical Research Director of Cholesterol Center
Jewish Hospital

Charles Glueck, MD, is the Medical Director of Jewish Hospital Cholesterol Center in Cincinnati, Ohio. He has expertise in lipids, lipoproteins, interaction of atherosclerosis and thrombosis, thrombosis, human genetics, epidemiology, obstetrics and gynecology, and hematology. Dr Glueck and colleagues...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Review of Statistical Conclusions of National Trends in Psychotherapy by Office-Based Psychiatrists | 08-20-2008
Author: William Shannon, PhD, Founder and President, BioRankings, LLC

An August 2008 study analyzing the National Ambulatory Medical Care Survey (NAMCA) database shows a significant decrease in the amount of psychotherapy that psychiatrists are providing for their patients, while at the same time possibly showing an increase in medications prescribed. This correlation...

Biostatistical and Experimental Design Assessment of Research on Tau Tangle Targeting for Alzheimer’s Disease | 08-05-2008
Author: William Shannon, PhD, Founder and President, BioRankings, LLC

Slowing the progression of Alzheimer's disease by attacking tau tangles is a novel idea that should be considered a viable treatment alternative, especially in light of the failings of some recent beta-amyloid treatment strategies (e.g., Flurizan).   At the 2008 International Conference on...

Biostatistics: Subgroup Analysis in Clinical Trials | 12-28-2007
Author: William Shannon, PhD, Founder and President, BioRankings, LLC

The authors of this NEJM Special Report define subgroup analysis as “any evaluation of treatment effects for a specific end point in subgroups of patients defined by baseline characteristics.” When done appropriately, subgroup analysis are valuable. However, when done post hoc they can lead to incorrect...

GSK and Astra-Zeneca to have big losses in marketshare with generic carvedilol on market | 09-21-2007
Author: GLG Expert Contributor

Market impact is huge for many reasons. First, carvedilol is postulated to be a more effective beta blocker in the management of CHF with reduced ejection fraction compared to other generics and name brand ones on the market. This is based on a number of clinical trials demonstrating superiority in...

An also-ran in a crowded market | 05-21-2007
Author: GLG Expert Contributor

Because bone void fillers are approved as devices, not drugs, they do not need to demonstrate efficacy, just safety.   Orthopaedic surgeons are looking past bone void fillers to products that are more biologically active. 

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Academic Institution*

Most Common Job Types:

  • Physician - Attending Physician
  • Professor
  • Research Scientist
  • Director
  • Assistant Professor
  • Researcher
  • President

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-06T17:45:17.377